ISGyP Award for Best Posters by a Trainee as First Author

ISGyP awards the top three posters by a trainee as first author in gynecologic pathology section of the Stowell-Orbison competition at the USCAP annual meeting. First place receives US $500 and second and third places each receive US $250.

All voting members of the ISGyP Educational Committee to serve as judges to assess posters. Judges divided into two groups of four or five judges.

All judges have same scoring sheet (sent electronically pre meeting).

All Edcational Committee members attending USCAP will be asked to provide right of first refusal to poster judging duties. Ed Comm members with other ISGyP or USCAP duties should inform chairs prior to USCAP meeting.

Judges should score all 8 posters in contention during the time allocated.

* Prior award winners are not excluded from subsequent competitions.

* The winning abstract for the W. Dwayne Lawrence Best Platform Award will be excluded from the Best Poster Award competition.


 

Best Posters Award Recipients

Award Year Recipient Presentation
2021 Shaymaa Hegazy (1st place) DNA mismatch repair deficient non-neoplastic endometrial glands are common in Lynch syndrome patients and present at higher density compared to colorectal mucosa
2021 Simon Roy (2nd place) HPV-independent, p53 independent non-invasive verruciform lesions of the vulva: a comparison of clinical, histological and recurrence parameters
2021 Lawrence Hsy Lin (2nd place) Small tumor nests are associated with poor clinical outcome in clear cell carcinoma of ovary
2022 Felix Kommoss (1st place) Methylation Analysis Supports Classification of Endometrial Stromal Sarcomas with Variant BCOR and BCORL1 Alterations as High-Grade Endometrial Stromal Sarcomas
2022 Janira Navarro (2nd place) Utility of a Comprehensive NGS 523-Gene Panel for the Simultaneous Analysis of Homologous Recombination Deficiency Score and Percent Genomic Loss of Heterozygosity Using a Cytogenetic Software Applied to the Evaluation of Epithelial Ovarian Tumors
2022 Darin Dolezal (3rd place) Progressive microsatellite instability in recurrent MSI-H endometrial adenocarcinomas coincides with ARID1A frameshift and CTNNB1 mutations
2023 Phoebe Hammer (1st place, shared) TCGA Molecular Subgroup Shows Greater Prognostic Significance Than Histologic Diagnosis in High-Grade Endometrial Carcinomas with Spindled, Undifferentiated and Sarcomatous Components
2023 Neslihan Kayraklioglu (1st place, shared) High Tumor Mutational Burden Predicts Recurrence in Copy Number Low Early-Stage Endometrial Cancer and is Associated with ARID1A and TP53 Mutations
2023 Xiaoming Zhang (2nd place) High-Grade Transformation of Ovarian Serous Borderline Tumors: A Series and Literature Review
2024 Christopher Felicelli (1st place) Uterine Leiomyosarcoma Methylation Profiling Identifies Two Distinct Clusters With Unique Histologic and Clinical Behaviors
2024 Emily Towery (2nd place) Fumarate Hydratase-Deficient Uterine Smooth Muscle Tumors: Description of 107 Cases Highlighting Their Diagnostic Spectrum and Expanding Recognized Patterns to Include Intravenous Leiomyomatosis and Disseminated Peritoneal Leiomyomatosis
2024 Neslihan Kayraklioglu (3rd place) Endometrial Cancers with Low Level Microsatellite Instability: Classification Pitfalls and Practical Recommendations for Assigning Mismatch Repair Status by Next Generation Sequencing with MSIsensor and Ancillary Tests
2025 Anusha Vemuri (1st place) A Deeper Dive into POLE-Mutated Endometrial Carcinomas: The Contributions and Consequences of Tumor Mutational Burden
2025 Benjamin L. Coiner (2nd place, shared) CTNNB1-Mutant High Grade Endometrial Carcinoma: Clinical Outcomes and Prevalence of Pilomatrix-Like and Corded Hyalinized Morphologies in an Institutional Case Control Series
2025 Haley N. Corbin (2nd place, shared) Spatial Architecture of Tumor-Infiltrating Lymphocytes Is an Independent Prognostic Marker in Vulvar Squamous Cell Carcinomas: A Multi-Institutional Assessment from the Lower Genital Tract Carcinoma Study Group
2026 Blake Flood (1st place) Pathologic and Molecular Predictors of Immunotherapy Response In Endometrial Cancer Inform Outcomes Beyond TCGA Classification
2026 Ramon Lorenzo D. Labitigan (2nd place) Distinguishing Primary Ovarian Carcinoid from Secondary Involvement by Extra-Ovarian Metastatic Neuroendocrine Tumor (NET) Using Short Tandem Repeat (STR) Genotype Testing to Assess for Loss of Heterozygosity (LOH)
2026 Melissa Gildenberg (3rd place) When Endometrial Cancer Does Not Keep Its ProMisE: Benefits and Caveats of Universal Next Generation Sequencing for Molecular Classification



Chat With ISGYP

close
First Name *
Last Name *
Email *
Customer ID